These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 20099675)

  • 1. [Risk factors of bilateralization of breast cancer: description of five cases in Libreville (Gabon) and review of the literature].
    Mayi-Tsonga S; Kamga H; Meye JF; Belembaogo E
    Med Trop (Mars); 2009 Dec; 69(6):583-6. PubMed ID: 20099675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer in men: are there similarities with breast cancer in women?].
    Arnould N; Pouget O; Gharbi M; Brettes JP
    Gynecol Obstet Fertil; 2006 May; 34(5):413-9. PubMed ID: 16630739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.
    Nicoletto MO; Donach M; De Nicolo A; Artioli G; Banna G; Monfardini S
    Cancer Treat Rev; 2001 Oct; 27(5):295-304. PubMed ID: 11871866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
    Blakely LJ; Buzdar AU; Lozada JA; Shullaih SA; Hoy E; Smith TL; Hortobagyi GN
    Cancer; 2004 Feb; 100(3):465-9. PubMed ID: 14745861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for breast cancer in elderly women.
    Sweeney C; Blair CK; Anderson KE; Lazovich D; Folsom AR
    Am J Epidemiol; 2004 Nov; 160(9):868-75. PubMed ID: 15496539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of contralateral breast cancer.
    Chen Y; Thompson W; Semenciw R; Mao Y
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):855-61. PubMed ID: 10548312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
    Metcalfe K; Lynch HT; Ghadirian P; Tung N; Olivotto I; Warner E; Olopade OI; Eisen A; Weber B; McLennan J; Sun P; Foulkes WD; Narod SA
    J Clin Oncol; 2004 Jun; 22(12):2328-35. PubMed ID: 15197194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
    Robson M; Svahn T; McCormick B; Borgen P; Hudis CA; Norton L; Offit K
    Cancer; 2005 Jan; 103(1):44-51. PubMed ID: 15558796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of synchronous bilateral breast carcinomas. Report of 30 patients.
    Ben Hassouna J; Damak T; Chargui R; Slimene M; Chkir A; Ayadi MA; Mtallah M; Hechiche M; Gamoudi A; Khomsi F; Ben Dhiab T; Rahal K
    Tunis Med; 2008 Feb; 86(2):155-9. PubMed ID: 18444533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Shenton A; Maher ER; Watson E; Woodward E; Lalloo F; Easton DF; Evans DG
    Breast Cancer Res; 2006; 8(6):R72. PubMed ID: 17187672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
    Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
    Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risk factors, diagnosis and treatment in carcinoma breast--a retrospective study.
    Bhattacharya S; Adhikary S
    Kathmandu Univ Med J (KUMJ); 2006; 4(1):54-60. PubMed ID: 18603869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerous high-risk epithelial lesions in familial breast cancer.
    Hoogerbrugge N; Bult P; Bonenkamp JJ; Ligtenberg MJ; Kiemeney LA; de Hullu JA; Boetes C; Niermeijer MF; Brunner HG
    Eur J Cancer; 2006 Oct; 42(15):2492-8. PubMed ID: 16908132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.